Home / NYT / CureVac’s mRNA vaccine reaches an efficacy level of just 47 percent in a clinical trial.

CureVac’s mRNA vaccine reaches an efficacy level of just 47 percent in a clinical trial.

Virual stuff June 16, 2021 NYT

By BY CARL ZIMMER from NYT Health https://ift.tt/2S4aRhB

CureVac’s mRNA vaccine reaches an efficacy level of just 47 percent in a clinical trial.

CureVac’s mRNA vaccine reaches an efficacy level of just 47 percent in a clinical trial.

Reviewed by Virual stuff on June 16, 2021 Rating: 5

No comments:

Subscribe to: Post Comments ( Atom )